Temporal Trends and Clinician Variability in Potassium Monitoring of Healthy Young Women Treated for Acne With Spironolactone.

  title={Temporal Trends and Clinician Variability in Potassium Monitoring of Healthy Young Women Treated for Acne With Spironolactone.},
  author={John S. Barbieri and David J. Margolis and Arash Mostaghimi},
  journal={JAMA dermatology},
Importance Although recent studies and guideline recommendations indicate that potassium level monitoring is of low usefulness for healthy young women being treated for acne with spironolactone, little is known about whether these recommendations have been implemented in clinical practice. Objective To evaluate trends in rates of potassium level monitoring among young women treated for acne with spironolactone and clinician variability in monitoring practices. Design, Setting, and… 
2 Citations
Spironolactone in dermatology
The use of spironolactone in different skin diseases that are common in the authors' environment, dosage according to different studies, treatment recommendations and adverse effects; all of the above mentioned in order to use this drug in a daily clinical practice are discussed.
Management of Acne Vulgaris: A Review.
Isotretinoin is approved by the US Food and Drug Administration for treating severe recalcitrant nodular acne but is often used to treat resistant or persistent moderate to severe acne, as well as acne that produces scarring or significant psychosocial distress.


Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne.
Routine potassium monitoring is unnecessary for healthy women taking spironolactone for acne, and the rate of hyperkalemia in healthy youngWomen taking sp ironolact one for acne is equivalent to the baseline rate ofhyperkalemicemia in this population.
Frequency of Primary Nonadherence to Acne Treatment.
Primary adherence to an acne treatment regimen is better when only 1 treatment is prescribed, and some patients may not complete acne treatment because 1 or more of their medications were never obtained.
Adherence to drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: the ACTUO observational prospective multicenter cohort trial in 643 patients
A good adherence to adjuvant treatment was associated with improved adherence and better treatment outcomes in mild to moderate acne patients, unlike those that despite adherence with medication had a low adhere to adjuvants.
Validating the diagnostic code for acne in a tertiary care dermatology centre
It is shown that ICD-9 code 706 can be used to accurately identify patients with acne in a dermatology setting and can be applied to future epidemiologic studies.